热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE anti-mouse CD135 Antibody
产品名称：
PE anti-mouse CD135 Antibody
产品类别：
抗体
产品编号：
135305
产品应用：
135305
[价格]
规格 价格 库存
50µg ￥ 1404 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse Flt3 transfected cell line
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application References

(PubMed link indicates BioLegend citation)
  1. Sergejeva S, et al. 2004. Blood 103:1270.
  2. Auffray C, et al. 2009. J. Exp. Med. 206:595.
  3. Chiba H, et al. 2013. Am J Physiol Cell Physiol. 305:693. PubMed
Product Citations
  1. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  2. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  3. Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
  4. Delbridge AR, et al. 2017. Cell Death Dis. 8:e2914. PubMed
  5. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  6. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  7. Hu X, et al. 2016. Nat Commun. 7:13095. PubMed
  8. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  9. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  10. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  11. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  12. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  13. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  14. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  15. Kinkel SA, et al. 2022. iScience. 25:104684. PubMed
  16. Carpenter RS, et al. 2020. Nat Commun. 3.029166667. PubMed
  17. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  18. Di Genua C, et al. 2020. Cancer Cell. 37(5):690-704.e8.. PubMed
  19. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  20. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  21. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  22. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  23. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  24. Qian J, et al. 2021. Int J Mol Sci. 22:. PubMed
  25. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  26. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  27. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  28. Fang H, et al. 2020. Nat Commun. 4.661805556. PubMed
  29. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  30. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  31. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  32. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  33. Sabnis A, et al. 2009. PLoS One. 7:e59. PubMed
  34. Kim SK, et al. 2018. Genes Dev. 32:849. PubMed
  35. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  36. Viaud M, et al. 2020. Cell Reports. 30(10):3397-3410. PubMed
  37. Jackson JT, et al. 2018. Blood Adv. 2:347. PubMed
  38. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  39. Dingler FA, et al. 2020. Mol Cell. . PubMed
  40. Giotopoulos G, et al. 2015. J Exp Med. 212: 1551-1569. PubMed
  41. Yá?ez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  42. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID
AB_1877218 (BioLegend Cat. No. 135305) AB_1877217 (BioLegend Cat. No. 135306)

Antigen Details

Structure
A 135-150 kD molecule belonging to the tyrosine kinase receptor family.
Distribution

Expressed on early B lymphoid lineage cells in juvenile and adult bone marrow, primitive myeloid progenitors within the BM CD34+ cell population.

Function
Regulate the growth of hematopoietic stem cells and promote the survival of primitive hematopoietic progenitor cells.
Ligand/Receptor
Flk-2/FLT3 ligand
Cell Type
B cells, Hematopoietic stem and progenitors
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Waskow C, et al.Nat. Immunol. 9:676
2. Veiby OP, et al. 1996. Blood 88(4):1256
3. Veiby OP, et al. 1996. J. Immunol. 157(7):2953
4. Mattews W, et al. 1991. Cell. 65(7):1143
5. Hannum C, et al. 1994. Nature 368(2):643
6. Ogawa M, et al. 1998. Exp Hematol. 26(6):478

Gene ID
14255 View all products for this Gene ID
UniProt
View information about CD135 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线